118 related articles for article (PubMed ID: 2120833)
21. Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors.
Acquaye JK; Tettey-Donkor D
West Afr J Med; 2000; 19(4):239-41. PubMed ID: 11391831
[TBL] [Abstract][Full Text] [Related]
22. Association of HCV and Treponema pallidum infection in HIV infected northeastern Thai male blood donors.
Barusrux S; Urwijitaroon Y; Puapairoj C; Romphruk A; Sriwanitchrak P
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S106-11. PubMed ID: 9347656
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
24. [Anti-hepatitis C prevalence and incidence in 2.8 million blood donors in Lower Saxony--residual transfusion-associated HCV risk].
Diekamp U; Kamutzky K; Windel CD
Beitr Infusionsther Transfusionsmed; 1997; 34():5-10. PubMed ID: 9417352
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
Monteleone PM; Andrzejewski C; Kelleher JF
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
[TBL] [Abstract][Full Text] [Related]
27. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission.
Di Stefano R; Stroffolini T; Ferraro D; Usticano A; Valenza LM; Montalbano L; Pomara G; Craxì A
J Med Virol; 2002 Jul; 67(3):339-44. PubMed ID: 12116024
[TBL] [Abstract][Full Text] [Related]
28. [Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China].
Tang S
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):271-4. PubMed ID: 7511060
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis virus C: from discovery to applications in public health].
Trépo C
Rev Prat; 1990 Jun; 40(18):1631-9. PubMed ID: 2115200
[TBL] [Abstract][Full Text] [Related]
30. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
31. Viral hepatitis in Nigeria--sickle-cell disease and commercial blood donors.
Mutimer DJ; Olomu A; Skidmore S; Olomu N; Ratcliffe D; Rodgers B; Mutimer HP; Gunson BK; Elias E
QJM; 1994 Jul; 87(7):407-11. PubMed ID: 7922292
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.
King SD; Dodd RY; Haynes G; Wynter HH; Sullivan MT; Serjeant GR; Choo-Kang E; Michael E
West Indian Med J; 1995 Jun; 44(2):55-7. PubMed ID: 7545339
[TBL] [Abstract][Full Text] [Related]
33. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
34. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
[TBL] [Abstract][Full Text] [Related]
35. [Expanded serologic infection testing of autologous blood donors: a report of experiences].
Zimmermann R; Weisbach V; Wittmann G; Zingsem J; Neidhardt B; Eckstein R
Beitr Infusionsther Transfusionsmed; 1996; 33():196-200. PubMed ID: 8974693
[TBL] [Abstract][Full Text] [Related]
36. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
Sakarya S; Oncu S; Ozturk B; Oncu S
Saudi Med J; 2004 Aug; 25(8):1070-2. PubMed ID: 15322600
[TBL] [Abstract][Full Text] [Related]
37. [HCV antibodies in selected patient groups and blood donors].
Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of anti-HCV antibodies in France. Viral Hepatitis Study Group of the French Blood Transfusion Society.
Aguelles O; Janot C
Arch Virol Suppl; 1992; 4():249-52. PubMed ID: 1450696
[TBL] [Abstract][Full Text] [Related]
39. Seroprevalence and significance of antibodies to hepatitis C virus in pediatric patients with malignant diseases.
Schneppenheim R; Rautenberg P; Behnke H; Vietor K
Klin Padiatr; 1991; 203(4):273-5. PubMed ID: 1658430
[TBL] [Abstract][Full Text] [Related]
40. [Antibodies against hepatitis C virus. Study in voluntary blood donors. Cuba 1991].
Galban García E; Padrón G; Arus Soler E; González O; Rodríguez Z; Mora S; Brito M
G E N; 1992; 46(1):10-4. PubMed ID: 1339033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
